Infektionskontrolle bei hämatologischen und onkologischen Neoplasien

Onkologische Patienten haben durch zytostatische Therapien häufig ein geschwächtes Immunsystem. Neben einem kontinuierlichen Monitoring des Immunstatus sind häufig weitere supportive Maßnahmen zur Infektionskontrolle erforderlich.

Publikationsverlauf

Artikel online veröffentlicht:
04. Juni 2020

• Literatur

• 1 Weide R, Feiten S, Chakupurakal G. et al. Survival improvement of patients with chronic lymphocytic leukemia (CLL) in routine care 1995–2017. Leuk Lymphoma 2020; 61: 557-566
• 2 Ailawadhi S, Jagannath S, Narang M. et al. Connect MM Registry as a national reference for United States multiple myeloma Patients. Cancer Med 2020; 9: 35-42
• 3 Weide R, Rendenbach B, Grundheber M. et al. Standard of care of patients with Chronic Myeloid Leukemia (CML) treated in community based oncology group practices between 2001–2015 in Rhineland-Palatinate (Germany). Appl Cancer Res 2017; 37: 26
• 4 Klastersky J, de Naurois J, Rolston K. et al. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol 2016; 27 (Suppl. 05) v111-v118
• 5 Ramsay AG, Johnson AJ, Lee AM. et al. Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J Clin Invest 2008; 118: 2427-2437
• 6 Aranow C. Vitamin D and the Immune system. J Investig Med 2011; 59: 881-886
• 7 Weide R, Feiten S, Friesenhahn V. et al. Immunoglobulin substitution in patients with indolent non-Hodgkin’s lymphoma. Dtsch Med Wochenschr 2015; 140: e201-e206
• 8 Guideline on core SmPC for human normal immunoglobulin for intravenous administration (IVIg). https://www.ema.europa.eu/documents/scientific-guideline/guideline-core-smpc-human-normal-immunoglobulin-intravenous-administration-ivig-rev-5_en.pdf
• 9 Maschmeyer G, De Greef J, Mellinghoff SC. et al. Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL). Leukemia 2019; 33: 844-862
• 10 www.onkopedia.com/de/onkopedia/guidelines/antivirale-prophylaxe/@@guideline/html/index.html
• 11 Ruchlemer R, Ben-Ami R, Bar-Meir M. et al. Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study. Mycoses 2019; 62: 1140-1147
• 12 www.onkopedia.com/de/onkopedia/guidelines/antimykotische-primaerprophylaxe-bei-patienten-mit-haematologischen-neoplasien/@@guideline/html/index.html